111 (YI) Return on Invested Capital (2024 - 2025)
111 (YI) posted Return on Invested Capital of 0.0% for Q4 2025, up 76.25% sequentially from 0.0% in Q3 2025, and little changed YoY from 0.0% in Q4 2024.
111 (YI) Return on Invested Capital (2024 - 2025) Analysis & Trends
111 has reported Return on Invested Capital for 2 years, with the latest figure at 0.0% in Q4 2025.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital climbed to 0.0% in Q4 2025 per YI's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.0% in Q4 2024 and troughed at 0.01% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 0.00% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 0.02% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 0.00% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 0.00% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -0.03% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 0.00% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -0.01% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |